National Center for Tumor Diseases

250.6k citations
6.1k papers ·

Impact in

  • Genetics top 1%
    • Glioma Diagnosis and Treatment
    • Virus-based gene therapy research
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care

Papers in

    • Cancer Immunotherapy and Biomarkers 384
    • Cancer survivorship and care 252
    • Glioma Diagnosis and Treatment 435
    • Virus-based gene therapy research 173

National Center for Tumor Diseases

5.7k papers receiving 250.5k citations

Peers

National Center for Tumor Diseases
Comparison fields: 5 of 233
  • Genetics 28.8k
  • Oncology 60.2k
  • Health Informatics 4k
  • Cancer Research 20.2k
  • Hematology 15.3k
Replace Deutsches Konsortium für Translationale Krebsforschung with:
Deutsches Konsortium für Translationale Krebsforschung Germany
University Medical Centre Mannheim Germany
Novartis (Switzerland) Switzerland
Roche (Switzerland) Switzerland
IRCCS Humanitas Research Hospital Italy
Erasmus MC Cancer Institute Netherlands
European Institute of Oncology Italy
Fondazione IRCCS Istituto Nazionale dei Tumori Italy
Hôpital Saint-Antoine France
Novartis Institutes for BioMedical Research
National Center for Tumor Diseases relative to Deutsches Konsortium für Translationale Krebsforschung Germany Deutsches Konsortium für Translationale Krebsforschung's profile →
Citations per field
00.5×1.7×
Deutsches Konsortium für Translationale Krebsforschung · 1×
Citations per year

Countries citing scholars working at National Center for Tumor Diseases

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at National Center for Tumor Diseases. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National Center for Tumor Diseases with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National Center for Tumor Diseases more than expected).

Fields of papers published by authors at National Center for Tumor Diseases

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with National Center for Tumor Diseases at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National Center for Tumor Diseases at the time of their publication.

About National Center for Tumor Diseases

In recent decades, authors affiliated with National Center for Tumor Diseases have published 6.1k papers, which have received a total of 250.6k indexed citations . Scholars at this organization have produced 1.6k papers in Oncology, 531 papers in Genetics, 107 papers in Health Informatics, 534 papers in Hematology and 497 papers in Cancer Research on the topics of Glioma Diagnosis and Treatment (435 papers), Cancer Immunotherapy and Biomarkers (384 papers), Multiple Myeloma Research and Treatments (339 papers), Cancer survivorship and care (252 papers), Breast Cancer Treatment Studies (220 papers), Radiation Therapy and Dosimetry (217 papers), Cancer Genomics and Diagnostics (178 papers) and Virus-based gene therapy research (173 papers). Their work is cited by papers focused on Genetics (28.8k citations), Oncology (60.2k citations), Health Informatics (4k citations), Cancer Research (20.2k citations) and Hematology (15.3k citations). Authors at National Center for Tumor Diseases collaborate with scholars in Germany, United States and United Kingdom and have published in prestigious journals including Cancers, Annals of Oncology, International Journal of Cancer, Blood and European Journal of Cancer. Some of National Center for Tumor Diseases's most productive authors include Hermann Brenner, Wolfgang Wick, Zuguang Gu, Andreas Schneeweiss, Jürgen Debus, Jakob Nikolas Kather, Andreas von Deimling, Michael Platten, Dirk Jäger and Michael Weller.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact